| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,566 | 2,807 | 2,837 | 2,992 | | Cost of Revenue | 836 | 892 | 896 | 886 | | | Gross Profit |
-
| 1,915 | 1,941 | 2,106 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,218 | 1,781 | 1,617 | 1,383 | | Non Recurring | (584) | 143 | 441 | 1,553 | | Others | 198 | 130 | 30 | 52 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (139) | (147) | (882) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (102) | (139) | (147) | (882) | | Interest Expense | 438 | 467 | 483 | 511 | | Income Before Tax | (540) | (606) | (630) | (1,393) | | Income Tax Expense |
-
| (21) | (67) | (256) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (540) | (585) | (563) | (1,137) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (540) | (585) | (563) | (1,137) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($540) | ($585) | ($563) | ($1,137) |
|
0.11% Nasdaq 
0.07%
Income Statement
